INDIA RUPEE-Heavy RBI intervention helps rupee log best week in 19 months

Reuters
02-14
INDIA RUPEE-Heavy RBI intervention helps rupee log best week in 19 months

By Siddhi Nayak

MUMBAI, Feb 14 (Reuters) - The Indian rupee logged its biggest weekly rise against the dollar in seven months, lifted by the central bank's heavy intervention in the foreign exchange market and kept speculators betting against the currency at bay.

The rupee INR=IN ended at 86.8225 per U.S. dollar, up 0.1% compared to 86.8975 in the previous session. However, for the week, the rupee rose 0.7%, the most since mid-July 2023.

The domestic unit has been under pressure amid India's sluggish economic growth, a recent interest rate cut by the Reserve Bank of India (RBI), foreign outflows from local stocks and concerns of a global trade war following U.S. President Donald Trump's tariff plans.

On Monday, the rupee slipped to an all-time low of 87.95 against the dollar, but the fall was limited as the RBI intervened by selling dollars in the spot market. The central bank is also believed to have stepped in on Tuesday.

DBS Bank expects that the RBI sold $10 billion, while Goldman Sachs' estimate is close to $11 billion. The quantum surprised the market as the central bank's involvement had reduced since the appointment of Sanjay Malhotra as governor in mid-December.

"The RBI's firm and calculated measures, are expected to cushion volatility and provide the rupee with a firmer footing," said Amit Pabari, managing director at FX advisory firm CR Forex.

The rupee is expected to trade within the 86.60–87.20 range in the near term, he said.

While the near-term forward rose this week, far forwards dropped, thanks to buy/sell swaps by the RBI.

Meanwhile, Asian currencies were mostly higher on the day on relief that Trump's reciprocal tariff plan will not be implemented immediately.

The dollar index =USD dropped 0.8% to its lowest level in more than two weeks on Friday. U.S. Treasury yields dropped and Wall Street rallied overnight.

(Reporting by Siddhi Nayak; Editing by Sonia Cheema)

((siddhi.nayak@tr.com))

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10